Schizophrenia trials in Malaysia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

  Where

  Kangar, Kuala Lumpur, Kuching, Sungai Petani

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Newron Pharmaceuticals SPA

  See details and how to joinNCT07184619